Fast Track Approval of cancer drug evofosfamide of Merck KGaA & Threshold Pharmaceuticals

Germany’s Merck KGaA said that experimental cancer drug evofosfamide, which it is jointly developing with Threshold Pharmaceuticals, won fast track status for... Read More